Markets
markets

Abbott slumps after reporting sales miss, disappointing Q1 guidance

Abbott Laboratories fell in premarket trading after it reported fourth-quarter sales that missed Wall Street estimates and gave disappointing guidance for the current quarter.

The company said it expects to report first-quarter adjusted earnings per share of between $1.12 and $1.18, below the $1.20 analysts polled by FactSet were expecting. For the full year, it expects to report adjusted earnings per share of $5.55 to $5.80, in line with the $5.67 the Street is penciling in.

Abbott also reported $11.5 billion in sales for the fourth quarter, less than the analyst consensus of $11.8 billion. The sales miss was driven by lower-than-expected sales of its medical devices, its largest segment. Its profits for the quarter hit $1.50 per share, right in line with expectations.

The stock fell more than 5% in premarket trading on Thursday.

More Markets

See all Markets
markets

SpaceX gets a wave of bullish ratings from Wall Street analysts

SpaceX received more than a dozen positive analyst calls on Tuesday — including from major Wall Street banks — as they initiate coverage on Elon Musk’s space and AI company.

SpaceX went public on June 12 at a $2.2 trillion valuation, the largest debut in history. While the company hasn’t yet posted a profit, it seems to have convinced Wall Street that it will get there and grow its valuation on the way.

Of the at least 17 analysts that gave a rating on Tuesday, all but one gave it a “buy” or “outperform” rating. MoffettNathanson was "neutral."

The ratings come as SpaceX joined the Nasdaq 100 index, a benchmark tech-heavy basket of companies that underpins millions of portfolios. The inclusion adds built-in demand for the stock from index funds and ETFs.

Still, SpaceX fell more than 5% on Tuesday amid a broader sell-off, and is currently effectively flat from its opening price of $150 a share.

Latest Stories

Sherwood Media, LLC and Chartr Limited produce fresh and unique perspectives on topical financial news and are fully owned subsidiaries of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Money, LLC, Robinhood U.K. Ltd, Robinhood Derivatives, LLC, Robinhood Gold, LLC, Robinhood Asset Management, LLC, Robinhood Credit, Inc., Robinhood Ventures DE, LLC and, where applicable, its managed investment vehicles.